Elucidation of the anti-inflammatory mechanism of erythromycin mediated by DEL-1: Establishment of the therapeutic effect of erythromycin on pneumonia and periodontitis
August 07, 2020
A global study conducted by researchers at the Niigata University Graduate School of Medical and Dental Sciences including Associate Professor Tomoki Maekawa (also a research professor at the Institute for Research Promotion) and Professor Takeyasu Maeda of the Center for Advanced Oral Science, Professor Yutaka Terao of the Division of Microbiology and Infectious Diseases, and Professor Koichi Tabeta of the Division of Periodontology, in collaboration with the Kyoto Pharmaceutical University, the University of Pennsylvania in the US, and the Technical University of Dresden in Germany, revealed that the macrolide antibiotic erythromycin exhibited anti-inflammatory activity against pneumonia and periodontitis by inducing DEL-1.
Publication Details
Title: Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1
Journal: JCI Insight
Authors: Tomoki Maekawa, Hikaru Tamura, Hisanori Domon, Takumi Hiyoshi, Toshihito Isono, Daisuke Yonezawa, Naoki Hayashi, Naoki Takahashi, Koichi Tabeta, Takeyasu Maeda, Masataka Oda, Athanasios Ziogas, Vasileia I. Alexaki, Triantafyllos Chavakis, Yutaka Terao and George Hajishengallis
DOI: 10.1172/jci.insight.136706
More News
-
Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform
Research results
-
Hidden Acid Imbalance in Kidney Disease Raises Red Flags
Research results
-
Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort
Research results
-
From surface to depth: 3D imaging traces vascular amyloid spread in the human brain
Research results